Denintuzumab Mafodotin Stimulates Immune Responses and Synergizes with CD20 Antibodies to Heighten Anti-Tumor Activity in Preclinical Models of Non-Hodgkin Lymphoma
- Resource Type
- Abstract
- Source
- In
Blood 2 December 2016 128(22):4177-4177 - Subject
- Language
- ISSN
- 0006-4971